Human papillomavirus infection and cervical cancer prevention in Indonesia

Yanjia Li

doi:10.1117/12.2670404

24 March 2023 Human papillomavirus infection and cervical cancer prevention in Indonesia

Yanjia Li

Proceedings Volume 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022); 126112B (2023) https://doi.org/10.1117/12.2670404
Event: International Conference on Biological Engineering and Medical Science (ICBioMed2022), 2022, Oxford, United Kingdom

Abstract

Cervical cancer is commonly caused by human papillomavirus infection. However, cervical cancer is one that can be prevented. In this article, the authors wish to use secondary data to assess cervical cancer incidence and mortality in Indonesia, which has almost the most frequent incidence of cervical cancer in Asia. As a developing country, the authors also explored the effectiveness of screening and vaccination in the country. Clearly, screening and vaccination coverage in Indonesia is low, so the authors also describe the possibility of improving Indonesia's ability to prevent cervical cancer in the future. In November 2020, the World Health Organization is preparing to launch a worldwide strategy to accelerate the elimination of cervical cancer as a public health issue. Projections suggest that Indonesia could avoid more than 3 million deaths from cervical cancer over the next century if the three major elimination strategies (vaccinations, screening strategies, and treatments) were perfected. As a result, the authors found that while HPV coverage in Indonesia is very low across Asia and there is no awareness of prevention, WHO could try to initiate this broad strategy to accelerate the eradication of cervical cancer as a public health issue, focusing on three early stages Areas such as screening, vaccines and treatments will provide women in Indonesia with a promising future.

Citation Download Citation

Yanjia Li "Human papillomavirus infection and cervical cancer prevention in Indonesia", Proc. SPIE 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022), 126112B (24 March 2023); https://doi.org/10.1117/12.2670404

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
8 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Cervical cancer

Cancer

Diseases and disorders

Cell biology

Forensic DNA analysis

Medicine

Safety

Show All Keywords

Keywords/Phrases

Search In:

Publication Years